Earnings Feed
Start Free
Home/Filings/4/0001127602-14-027224
4//SEC Filing

CONMED CORP 4

Accession 0001127602-14-027224

$CNMDCIK 0000816956operating
View on SEC.govCompany Profile

Filed

Sep 3, 8:00 PM ET

Accepted

Sep 4, 5:13 PM ET

Size

49.9 KB

Accession

0001127602-14-027224

Insider Transaction Report

Form 4
Period: 2014-09-02
CONMED CORPCNMD
ABRAHAM WILLIAM
Senior Vice President
Transactions
  • Tax Payment

    Common Stock

    2014-09-03$39.89/sh−1,972$78,663→ 3,210 total
  • Exercise/Conversion

    Common Stock

    2014-09-03$16.46/sh+5,000$82,300→ 8,210 total
  • Tax Payment

    Common Stock

    2014-09-03$39.89/sh−3,124$124,616→ 5,086 total
  • Exercise/Conversion

    Common Stock

    2014-09-03$19.26/sh+4,000$77,040→ 9,086 total
  • Exercise/Conversion

    Common Stock

    2014-09-03$27.63/sh+3,000$82,890→ 9,407 total
  • Tax Payment

    Common Stock

    2014-09-03$39.89/sh−2,411$96,175→ 6,996 total
  • Exercise/Conversion

    Common Stock

    2014-09-02$31.40/sh+10,000$314,000→ 11,486 total
  • Sale

    Common Stock

    2014-09-02$39.76/sh−10,000$397,564→ 1,486 total
  • Exercise/Conversion

    Common Stock

    2014-09-03$19.93/sh+2,500$49,825→ 3,986 total
  • Tax Payment

    Common Stock

    2014-09-03$39.89/sh−1,702$67,893→ 2,284 total
  • Tax Payment

    Common Stock

    2014-09-03$39.89/sh−2,102$83,849→ 2,682 total
  • Tax Payment

    Common Stock

    2014-09-03$39.89/sh−2,679$106,865→ 6,407 total
  • Exercise/Conversion

    Common Stock

    2014-09-03$32.93/sh+1,000$32,930→ 8,437 total
  • Tax Payment

    Common Stock

    2014-09-03$39.89/sh−889$35,462→ 7,548 total
  • Sale

    Common Stock

    2014-09-04$40.16/sh−6,062$243,446→ 1,486 total
  • Exercise/Conversion

    Options To Purchase Common Stock

    2014-09-02−10,000→ 0 total
    Exercise: $31.40From: 2005-11-17Exp: 2015-05-17→ Common Stock (10,000 underlying)
  • Exercise/Conversion

    Sars (Stock Appreciation Rights)

    2014-09-03−2,500→ 0 total
    Exercise: $29.92Exp: 2017-05-17→ Common Stock (2,500 underlying)
  • Exercise/Conversion

    Sars (Stock Appreciation Rights)

    2014-09-03−2,500→ 0 total
    Exercise: $26.69Exp: 2018-06-01→ Common Stock (2,500 underlying)
  • Exercise/Conversion

    Sars (Stock Appreciation Rights)

    2014-09-03−5,000→ 0 total
    Exercise: $16.46Exp: 2019-06-01→ Common Stock (5,000 underlying)
  • Exercise/Conversion

    Sars (Stock Appreciation Rights)

    2014-09-03−3,000→ 2,000 total
    Exercise: $27.63Exp: 2021-06-01→ Common Stock (3,000 underlying)
  • Exercise/Conversion

    Sars (Stock Appreciation Rights)

    2014-09-03−2,000→ 3,000 total
    Exercise: $26.09Exp: 2022-06-01→ Common Stock (2,000 underlying)
  • Exercise/Conversion

    Common Stock

    2014-09-03$26.69/sh+2,500$66,725→ 5,182 total
  • Exercise/Conversion

    Sars (Stock Appreciation Rights)

    2014-09-03−4,000→ 1,000 total
    Exercise: $19.26Exp: 2020-06-01→ Common Stock (4,000 underlying)
  • Exercise/Conversion

    Common Stock

    2014-09-03$29.92/sh+2,500$74,800→ 4,784 total
  • Exercise/Conversion

    Sars (Stock Appreciation Rights)

    2014-09-03−1,000→ 4,000 total
    Exercise: $32.93Exp: 2023-06-01→ Common Stock (1,000 underlying)
  • Exercise/Conversion

    Common Stock

    2014-09-03$26.09/sh+2,000$52,180→ 8,996 total
  • Tax Payment

    Common Stock

    2014-09-03$39.89/sh−1,559$62,189→ 7,437 total
  • Exercise/Conversion

    Sars (Stock Appreciation Rights)

    2014-09-03−2,500→ 0 total
    Exercise: $19.93Exp: 2016-05-16→ Common Stock (2,500 underlying)
Footnotes (5)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.75 to $39.83. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.08 to $40.30. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.
  • [F3]The stock appreciation rights ("SARs") were granted under the Issuer's 2006 Stock Incentive Plan and generally vest in equal amounts over a five year period.
  • [F4]The stock appreciation rights ("SARs") were granted under the Company's 2006 Stock Incentive Plan and generally vest in equal amounts over a five year period.
  • [F5]The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.

Documents

1 file

Issuer

CONMED CORP

CIK 0000816956

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000816956

Filing Metadata

Form type
4
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 5:13 PM ET
Size
49.9 KB
View on SEC.gov